Pharmacogenomics
(ISSN: 1462-2416)
Show only: Full-text on Medscape
2009 - 10 (6)
- Genetic variation in the rhythmonome: ethnic variation and haplotype structure in candidate genes for arrhythmias.
- Vitamin K epoxide reductase complex 1 (VKORC1) haplotypes in healthy Hungarian and Roma population samples.
- Statin regulation of CYP3A4 and CYP3A5 expression.
- Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs.
- ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells.
- Development of a new genotyping assay for detection of the BDNF Val66Met polymorphism using melting-curve analysis.
- Pharmacogenetic testing after a simple DNA isolation method on buccal swab samples.
- Systems biology in pharmacogenomic research: the way to personalized prescribing?
- Pharmacogenomics of adverse drug reactions: practical applications and perspectives.
- Human formyl peptide receptor 1 (FPR1) c.32C>T SNP is associated with decreased soluble E-selectin levels.
- Impact of apolipoprotein A5 variants on statin treatment efficacy.
- Dihydropyrimidine dehydrogenase gene variation and severe 5-fluorouracil toxicity: a haplotype assessment.
- Personalized therapy and pharmacogenomics: future perspective.
